Antiplaque comment deadline
This article was originally published in The Tan Sheet
Executive Summary
Comments on advance notice of proposed rulemaking for OTC Antigingivitis/Antiplaque Drug Products will be accepted until Nov. 25, FDA says in Federal Register notice scheduled for appearance Aug. 25. Reply comment period has been extended to Feb. 23, 2004. CHPA, CTFA jointly requested the extension to review data on ingredients the agency has proposed classifying as Category III in a July 15 petition (1"The Tan Sheet" July 28, 2003, In Brief)...